Clinical trial
A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy in Terms of Continence Rates
NCT05735223 is registered in ClinicalTrials.gov with Larkin Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy in Terms of Continence Rates
- Lead sponsor
- Larkin Health System
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2021
- Completion date
- January 15, 2023
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
erectile dysfunction following radical prostatectomy, incontinence stress, prostate adenocarcinoma